CATEGORIES: CMT Summit | CMT Update

Summit Speaker Spotlight: Gary Barg, The Fearless Caregiver

by | May 25, 2016 | 1 comment

GARY-caregiverThose caring for patients living with CMT are invaluable members of our community. Caregivers are on the frontlines every day, helping patients manage their daily struggles and challenges of living with CMT.

These selfless people need to be recognized for their commitment and dedication, and deserve their own advocacy platform and a strong, influential voice to represent them.

That undeniable voice for the caregiver is Gary Barg.

Noted speaker, author, and publisher on caregiving issues since 1995, Gary Barg is the CEO and Editor-In-Chief Caregiver Media Group, and Founder and Editor-In-Chief of the first national magazine for caregivers, Today’s Caregiver. He is also credited with creating the original online caregiver community, caregiver.com.

But he didn’t stop there! Gary created The Fearless Caregiver Conference, uniting caregivers across the world to share their knowledge, experience, and priceless wisdom. He is a published author of two books, “The Fearless Caregiver” and “Caregiving Ties That Bind.”

His many accomplishments and awards has earned Gary the spotlight, interviewing with highly recognized media outlets such as The Today Show, Bloomberg Radio Network, Time Magazine, The Wall Street Journal, and USAToday.

Gary has been a keynote speaker for many events across the U.S including:

  • The Huntington’s Disease Society of America
  • Massachusetts Multiple Sclerosis Society
  • The Sharing Wisdom Conference with Leeza Gibbons
  • World Congress on Disabilities
  • Living Longer/Living Better Conference

And Gary has Charcot-Marie-Tooth.

Although his busy schedule leaves little time to enjoy reading and traveling with his dog, Gary has been incredibly gracious to take the time to join us as one of our featured speakers at the first Patient-Centered Charcot-Marie-Tooth Summit.

Let’s hear more from Gary and what he hopes for this Summit:

HNF: Why did you choose your particular topic for the Summit?

Gary: I think it’s very important to discuss all partners within patient centered research outcomes, and that includes the interaction between caregivers and loved ones.

HNF: How has CMT affected your life?

Gary: CMT affects my life the more I age. I’m much more conscious of taking care of myself, and getting as much exercise as I am capable of handling.  

HNF: What do you hope attendees take away from the Summit?

Gary: Learn all you can from the experts and providers who are all dedicated to supporting people living with CMT/IN. Above all, we should take the time to learn from one another.

HNF: Anything else you’d like to share with the community?

Gary: You are not alone. Stay involved and don’t isolate yourselves, for the sake of what you can learn from others living with CMT/IN, as well as what you can teach.

We can’t wait to hear Gary at the Summit, as he imparts his knowledge and experience to an audience eager to learn more about caregiving and CMT.  

To learn more about the summit or register visit www.hnf-cure.org/cmtsummit/

Want to learn more about Gary or have a question for him?

Contact Information:

Website: Caregiver.com

Twitter: @todayscaregiver

Email: [email protected]

Video: An Advocate for ‘Fearless Caregivers’

Learn more on this topic

Related Blog Posts

Taking Matters Into Your Own Hands

Do you have a rare form of CMT?

We were contacted recently from a patient with CMT2D who was looking for advice on how to make a difference. Our recommendations for all people with an ultra-rare form of CMT who want to get involved:

Now GRIN is Accessible in 141 Different Languages!

Now GRIN is Accessible in 141 Different Languages!

The Global Registry for Inherited Neuropathies (GRIN) has implemented Google Translate. Why did we choose Google? Because Google is leading the way in teaching computers how to interpret meaning, avoiding the traditional method of decoding language.

Accelerating Patient Access to Investigational Drugs in 2015

Accelerating Patient Access to Investigational Drugs in 2015

Currently the FDA is working to update the process for physicians applying for accelerated patient access to investigational drugs, while the drug or biological product is being tested in clinical trials. This will also be important for the CMT community as clinical trials for this disease are being launched.

Do You Have Charcot-Marie-Tooth Type 4 (CMT4)? – We Need Your Help

Autosomal recessive demyelinating CMT4 patients present with earlyonset and slowly progressing symptoms. These include progressive distally accentuated weakness and atrophy of muscles in the lower limbs. In addition, patients may have weakness and atrophy of hands, sensory loss and pes cavus (high-arched feet), and walking difficulties. Further information on CMT4 can be found at Orphanet.

Hot Off the Press – Potential Treatment for CMT1A

Two recent publications from Pharnext describe a novel synergistic combination of 3 drugs (baclofen, naltrexone and sorbitol) and its effect on CMT1A both in the lab and in a phase II clinical trial. These 3 drugs already approved but for unrelated conditions, are combined at new optimal lower doses and under a new formulation. This novel potential therapeutic is called PXT-3003.

Support CMT Therapeutic Alliance

HNF has entered into a joint venture – the CMT Therapeutic Alliance – with a unique non profit organization (BioPontis Alliance for Rare Diseases) that brings professional drug discovery capabilities to translate our research results into potential treatments.

Scientific Advisory Board Meeting

Scientific Advisory Board Meeting

On the 7th of November we convened our scientific advisory board meeting at the HNF offices in NY. We have written a detailed review that has been published and captures all of the discussion and make this freely available to the scientific community.

Breaking News: First Therapeutic Gene Therapy to Treat an Inherited Neuropathy is Approved for Clinical Trial!

The first disease community to receive a therapeutic gene to the spinal cord for an ultra rare inherited neuropathy is Giant Axonal Neuropathy (GAN). Congratulations to Hannah’s Hope Fund (HHF), a 501(c)3 public charity, which has driven this collaborative research in less than six years. Six million dollars has been raised to date to fund pre-clinical and clinical research on this rare disease.

Join the conversation

Leave a Comment

1 Comment

  1. Linda Westmoreland

    Sometimes I think we don’t talk about our spouses, parents, friends or paid staff enough. I am still very independent, however, my husband does so many things for me. I don’t thank him enough! Actually, I feel like a spoiled brat! CMT is progressive and it sneaks up on us. We do less and less as time goes by. I was am extremely hard worker! I just wonder how my spouse feels about my decline. He would never say anything to offend me and that is why I love him so much. He’s not really a caretaker, but I feel there should be a recognition for these warriors who are behind us every step of the way.

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news